Evidence map›Paper›PMID 24603419›Full record

ArticleEye (London, England)2014

Melatonin and amfenac modulate calcium entry, apoptosis, and oxidative stress in ARPE-19 cell culture exposed to blue light irradiation (405 nm).

M Argun, L Tök, A C Uğuz, Ö Çelik, Ö Y Tök, M Naziroğlu

Open access · bronzeAbstract read
In one paragraph

Article in Eye (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Bevacizumab induces oxidative cytotoxicity and apoptosis via TRPM2 channel activation in retinal pigment epithelial cells: Protective role of glutathione.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M ArgunDepartment of Ophthalmology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
L TökDepartment of Ophthalmology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
A C Uğuz1] Department of Biophysics, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey [2] Neuroscience Research Center, Süleyman Demirel University, Isparta, Turkey.
Ö Çelik1] Department of Biophysics, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey [2] Neuroscience Research Center, Süleyman Demirel University, Isparta, Turkey.
Ö Y TökDepartment of Ophthalmology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
M Naziroğlu1] Department of Biophysics, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey [2] Neuroscience Research Center, Süleyman Demirel University, Isparta, Turkey.
Süleyman Demirel University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUnder conditions of oxidative stress, cell apoptosis is triggered through the mitochondrial intrinsic pathway. Increased levels of reactive oxygen species (ROS) are linked to excess cell loss and mediate the initiation of apoptosis in a diverse range of cell types. The aims of this study were to assess intracellular Ca(2+) release, ROS production, and caspase-3, and -9 activation in ARPE-19 cells during the blue light-mediated cell death, and to examine a potential protective effect of melatonin and amfenac, in the apoptotic cascade.

methodsARPE-19 cells were cultured in their medium. First, MTT tests were performed to determine the protective effects of amfenac and melatonin. Cells were then exposed to blue light irradiation in an incubator. Intracellular Ca(2+) release experiments, mitochondrial membrane depolarization, apoptosis assay, glutathione (GSH), glutathione peroxidase (GSH-Px), and ROS experiments were done according to the method stated in the Materials and methods section.

resultsCell death was clearly associated with increased levels of ROS production, as measured by 2',7'-dichlorofluorescein fluorescence, and associated increase in Ca(2+) levels, as measured by Fura-2-AM. Blue light-induced cell death was associated with an increased level of caspase-3 and 9, suggesting mediation via the apoptotic pathway. Cell death was also associated with mitochondrial depolarization. Melatonin was shown to delay these three steps.

conclusionMelatonin, amfenac, and their combination protect ARPE-19 cells against blue light-triggered ROS accumulation and caspase-3 and -9 activation. The antiapoptotic effect of melatonin and amfenac at doses inhibiting caspase synthesis modified Ca(2+) release and prevented excessive ROS production, suggesting a new therapeutic approach to age-related macular degeneration.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalAntioxidantsApoptosisCalciumCaspase 3Caspase 9Cell LineCell SurvivalDrug CombinationsGlutathioneGlutathione PeroxidaseHumansLipid PeroxidationMelatoninOxidative StressPhenylacetatesamfenacAnti-Inflammatory Agents, Non-SteroidalAntioxidantsCalciumCaspase 3Caspase 9Drug CombinationsGlutathioneGlutathione PeroxidaseMelatoninPhenylacetatesReactive Oxygen Species

Identifiers

PMID24603419
PMCPMC4058615
OpenAlexW2050219286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.